Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +17.01%
#3 Orochi Network Orochi Network +10.19%
#4 Pump.fun Pump.fun +9.55%
#5 Unit Pump Unit Pump +9.55%
#6 eCash eCash +9.31%
#7 Fake World Assets Fake World Assets +8.82%
#8 OPENLOOT OPENLOOT +8.48%
#9 Meteora Meteora +8.22%
#10 Glidr Glidr +8.12%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
HEXO Corp. HEXO Corp.

HEXO Corp.

HEXO
Rank in Stocks #28118
Operating through its various subsidiaries, HEXO Corp. engages in the... Operating through its various subsidiaries, HEXO Corp. engages in the cultivation, marketing, and distribution of cannabis products across Canada. Its comprehensive product line includes both recreational and medicinal cannabis, primarily sold under the HEXO brand. Furthermore, the company diversifies its offerings with cannabis-infused beverages from labels such as Little Victory, House of Terpenes, Mollo, Veryvell, and XMG, alongside other cannabis products available under the UP Cannabis, Original Stash, and Up brand names. HEXO Corp. also maintains a key strategic partnership with Tilray Brands, Inc. Established in 2013, the company initially operated as The Hydropothecary Corporation until it officially rebranded to HEXO Corp. in August 2018. Its corporate headquarters are situated in Gatineau, Canada.
Share Price
$0.64586446
Last synced: 2023-06-26
Market Cap
$28.42M
Change (1 day)
-1.90%
Change (1 year)
0.00%
Country
CA
Trade HEXO Corp. (HEXO)

Category

Healthcare
P/E ratio for HEXO Corp. (HEXO)
P/E ratio as of 2026 TTM: 0
According to HEXO Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for HEXO Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.